Hypertension in Asian/Pacific Island Americans

Journal of Clinical Hypertension

Volumn 11, Issue 3, 2009, Pages 148-152

  Watson, Ralph E ^a   Karnchanasorn, Rudruidee ^a   Gossain, Ved V ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROPRANOLOL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ALDOSTERONE BLOOD LEVEL; AMINO ACID SUBSTITUTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASIAN AMERICAN; CARDIOVASCULAR RISK; COUGHING; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HYPERTENSION; MEDICAL EDUCATION; PACIFIC ISLANDER; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; TEA;

ANTIHYPERTENSIVE AGENTS; ASIAN AMERICANS; ATTITUDE TO HEALTH; CULTURAL DIVERSITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH EDUCATION; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPERTENSION; MALE; NEEDS ASSESSMENT; OCEANIC ANCESTRY GROUP; PREVALENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 63349096929     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00088.x     Document Type: Article

References (46)

1. Chen MS Jr. Cancer health disparities among Asian Americans: What we do and what we need to do. Cancer. 2005;104(suppl 12):2895-2902.
2. A Brown Paper: The Health of South Asians in the U.S., 1st ed. Berkeley, CA: South Asian Public Health Association; 2002.
3. U.S. Census Bureau. We the people: Asians in the United States. Census 2000 Special Report; 2000.
4. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-e171.
5. Mensah GA, Mokdad AH, Ford ES, et al. State of disparities in cardiovascular health in the United States. Circulation. 2005;111:1233-1241.
6. Klatsky AL, Tekawa IS, Armstrong MA. Cardiovascular risk factors among Asian Americans. Public Health Rep. 1996;111(suppl 2):62-64.
7. Kim MT, Juon HS, Hill MN, et al. Cardiovascular disease risk factors in Korean American elderly. West J Nurs Res. 2001;23:269-282.
8. Barnes PM, Adams PF, Powell-Griner E. Health characteristics of the Asian adult population: United States, 2004-2006. Adv Data. 2008;394:1-22.
9. Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2005. Vital Health Stat 10. 2006;232:1-153.
10. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-e146.
11. Enas EA, Garg A, Davidson MA, et al. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J. 1996;48:343-353.
12. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75.
13. Katsuya T, Ishikawa K, Sugimoto K, et al. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res. 2003;26:521-525.
14. Lee YW, Oh VM, Garcia E, et al. Haplotypes of the beta2-adrenergic receptor gene are associated with essential hypertension in a Singaporean Chinese population. J Hypertens. 2004;22:2111-2116.
15. Sagnella GA, Rothwell MJ, Onipinla AK, et al. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J Hypertens. 1999;17:657-664.
16. Wong CC, Mouanoutoua V, Chen MJ, et al. Adherence with hypertension care among Hmong Americans. J Community Health Nurs. 2005;22:143-156.
17. Smith SC Jr, Clark LT, Cooper RS, et al. Discovering the full spectrum of cardiovascular diseaRe: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation. 2005;111:e134-e139.
18. Lau DS, Lee G, Wong CC, et al. Characterization of systemic hypertension in the San Francisco Chinese community. Am J Cardiol. 2005;96:570-573.
19. Lloyd-Jones DM, Sutton-Tyrrell K, Patel AS, et al. Ethnic variation in hypertension among premenopausal and perimenopausal women: Study of women's health across the nation. Hypertension. 2005;46:689-695.
20. Viera AJ, Kshirsagar AV, Hinderliter AL. Lifestyle modifications to lower or control high blood pressure: Is advice associated with action? The behavioral risk factor surveillance survey. J Clin Hypertens (Greenwich). 2008;10:105-111.
21. Moser M, Franklin SS. Hypertension management: Results of a new national survey for the hypertension education foundation: Harris interactive. J Clin Hypertens (Greenwich). 2007;9:316-323.
22. Zhou HH, Koshakji RP, Silberstein DJ, et.al. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med. 1989;320:565-570.
23. Zhou HH, Adedoyin A, Wilkinson GR. Differences in plasma binding of drugs between Caucasians and Chinese subjects. Clin Pharmacol Ther. 1990;48:10-17.
24. Ranade K, Jorgenson E, Sheu WH, et al. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet. 2002;70:935-942.
25. Wilk JB, Myers RH, Pankow JS, et al. Adrenergic receptor polymorphisms associated with resting heart rate: The HyperGEN Study. Ann Hum Genet. 2006;70(Pt 5):566-573.
26. Biolo A, Clausell N, Santos KG, et.al. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy. Am J Cardiol. 2008;102:726-732.
27. Mahesh Kumar KN, Ramu P, Rajan S, et al. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population. J Cardiovasc Pharmacol. 2008;52:459-466.
28. Brand E, Chatelain N, Mulatero P, et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 1998;32:198-204.
29. Matsubara M, Kikuya M, Ohkubo T, et.al. Aldosterone synthase gene (CYP11B2) C-334T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: The Ohasama Study. J Hypertens. 2001;19:2179-2184.
30. Tsujita Y, Iwai N, Katsuya T, et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: The suita study. Hypertens Res. 2001;24:105-109.
31. Tamaki S, Iwai N, Tsujita Y, et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension. 1999;33(1 Pt 2):266-270.
32. Saruta T, Kageyama S, Ogihara T, et al. Efficacy and safety of the selective aldosterone blocker eplerenone in Japanese patients with hypertension: A randomized, double-blind, placebo-controlled, dose-ranging study. J Clin Hypertens (Greenwich). 2004;6:175-183; quiz 184-185.
33. Tomlinson B, Woo J, Critchley JA, et al. Isradipine treatment for hypertension in general practice in Hong Kong. Chin Med J (Engl). 1992;105:446-450.
34. Stensvold I, Tverdal A, Solvoll K, et al. Tea consumption: Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev Med. 1992;21:546-553.
35. Wakabayashi K, Kono S, Shinchi K, et al. Habitual coffee consumption and blood pressure: A study of self-defense officials in Japan. Eur J Epidemiol. 1998;14:669-673.
36. Yokogoshi H, Kato Y, Sagesaka YM, et al. Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats. Biosci Biotechnol Biochem. 1995;59:615-618.
37. Yokogoshi H, Kobayashi M. Hypotensive effect of gamma-glutamylmethylamide in spontaneously hypertensive rats. Life Sci. 1998;62:1065-1068.
38. Abe Y, Umemura S, Sugimoto K, et al. Effect of green tea rich in gamma-aminobutyric acid on blood pressure of Dahl salt-sensitive rats. Am J Hypertens. 1995;8:74-79.
39. Bingham SA, Vorster H, Jerling JC, et al. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr. 1997;78:41-55.
40. Hodgson JM, Puddey IB, Burke V, et al. Effects on blood pressure of drinking green and black tea. J Hypertens. 1999;17:457-463.
41. Yang YC, Lu FH, Wu JS, et al. The protective effect of habitual tea consumption on hypertension. Arch Intern Med. 2004;164:1534-1540.
42. Woo KS, Nicholls MG. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol. 1995;40:141-144.
43. Woo KS, Norris RM, Nicholls G. Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol. 1995;75:967-968.
44. Ding PY, Hu OY, Pool PE, et al. Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors? J Hum Hypertens. 2000;14:163-170.
45. Sebastian JL, McKinney WP, Kaufman J, et al. Angiotensin-converting enzyme inhibitors and cough. Prevalence in an outpatient medical clinic population. Chest. 1991;99:36-39.
46. Simon SR, Black HR, Moser M, et al. Cough and ACE inhibitors. Arch Intern Med. 1992;152:1698-1700.